We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+10.25%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$339B
AUM Growth
+$32.7B
Cap. Flow
+$7.03B
Cap. Flow %
2.08%
Top 10 Hldgs %
18.14%
Holding
3,647
New
148
Increased
2,572
Reduced
501
Closed
58

Sector Composition

Rank Sector Weight
1 Technology 21.96%
2 Financials 12.71%
3 Healthcare 11.98%
4 Consumer Discretionary 10.85%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OLO
3176
DELISTED
Olo Inc
OLO
$458K ﹤0.01%
21,971
+11,302
+106% +$294K
AXDX
3177
DELISTED
Accelerate Diagnostics
AXDX
$455K ﹤0.01%
8,698
PAVM icon
3178
PAVmed
PAVM
$35.4M
$455K ﹤0.01%
410
+8
+2% +$17.4K
ZH
3179
Zhihu
ZH
$281M
$455K ﹤0.01%
13,661
+438
+3% +$20.9K
CDAK
3180
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$455K ﹤0.01%
40,827
EIGR
3181
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$451K ﹤0.01%
2,892
FLXS icon
3182
Flexsteel Industries
FLXS
$302M
$450K ﹤0.01%
16,739
DRIO icon
3183
DarioHealth
DRIO
$70.9M
$445K ﹤0.01%
1,712
NNBR icon
3184
NN Inc
NNBR
$255M
$444K ﹤0.01%
108,200
CTSO icon
3185
Cytosorbents Corp
CTSO
$22.7M
$441K ﹤0.01%
105,131
+2,253
+2% +$12.6K
FORA
3186
DELISTED
Forian
FORA
$441K ﹤0.01%
48,887
ITI
3187
DELISTED
Iteris, Inc.
ITI
$440K ﹤0.01%
109,958
+6,482
+6% +$31.4K
CTXR icon
3188
Citius Pharmaceuticals
CTXR
$15.6M
$438K ﹤0.01%
11,351
EVI icon
3189
EVI Industries
EVI
$181M
$438K ﹤0.01%
14,007
+1,588
+13% +$50.8K
SAP icon
3190
SAP
SAP
$212B
$436K ﹤0.01%
3,113
-492
-14% -$68.7K
CRMD icon
3191
CorMedix
CRMD
$591M
$430K ﹤0.01%
94,289
XBIT icon
3192
XBiotech
XBIT
$68M
$430K ﹤0.01%
38,608
NGNE icon
3193
Neurogene
NGNE
$656M
$428K ﹤0.01%
4,430
AMR icon
3194
Alpha Metallurgical Resources
AMR
$1.74B
$427K ﹤0.01%
6,988
GORV
3195
DELISTED
Lazydays
GORV
$426K ﹤0.01%
658
+50
+8% +$31.3K
ASLE icon
3196
AerSale
ASLE
$293M
$425K ﹤0.01%
23,926
+4,745
+25% +$88.5K
FRBK
3197
DELISTED
Republic First Bancorp Inc
FRBK
$425K ﹤0.01%
114,232
HLTH
3198
DELISTED
Cue Health Inc. Common Stock
HLTH
$424K ﹤0.01%
+31,563
New +$347K
VHC icon
3199
VirnetX Holding Corp
VHC
$54.4M
$422K ﹤0.01%
8,110
CARM
3200
DELISTED
Carisma Therapeutics
CARM
$421K ﹤0.01%
25,784
+1,507
+6% +$30.3K

Similar funds

Charles Schwab's Q4 2021 Portfolio in Review

As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Charles Schwab's Q4 2021 filing shows 148 new, 2,572 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
  • Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
  • Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
  • Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
  • Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
  • Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
  • Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.

Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.